Case Study: Novartis Vaccines & Diagnostics

Improved Visibility, Forecasting, Decision Making

Long development cycles, huge R&D investments, and a high chance of failure makes the pharmaceutical industry risky business. For Novartis Vaccines & Diagnostics, which develops preventive vaccines and diagnostic tools, optimal vaccine investment decisions are crucial to effective R&D pipeline management. It all starts with exceptional pipeline performance forecasts …